After receiving regulatory approval from the authorities last week, the blueprint to UCL-Ventura breathing aid – a Continuous Positive Airway Pressure (CPAP) device which helps Covid-19 patients with lung infections to breathe more easily – is now available for download by manufacturers, research institutions, healthcare providers and non-profits organisations in the fight against the coronavirus.
Developed jointly by the University College London Hospital (UCLH) and Mercedes-AMG High Performance Powertrains, the effort of which took fewer than 100 hours from initial meeting to the production of the first unit, the UCL-Ventura breathing aid is now in Mark II specifications which consumes 70% less oxygen compared to the Mark I model. The life-saving device is now being manufactured to a tune of up to 1,000 units a day using tools and machines that would normally produce F1 pistons and turbochargers!
The UCL-Ventura has already undergone patient evaluations at UCLH and sister hospitals in the London area after the UK Government placed an order for 10,000 units. The devices are entirely produced at the HPP technology centre in Brixworth, Northamptonshire which has been repurposed to meet the urgent demand for breathing aids.
CPAP machines work by pushing an air-oxygen mix into the mouth and nose of the patient at a continuous pressure, keeping airways open and increasing the amount of oxygen entering the blood stream. Invasive ventilators deliver breaths directly into the lungs but require heavy sedation and connection to a tube placed into the patient’s trachea (windpipe).
The breathing aid has been used extensively in hospitals in Italy and China to help Covid-19 patients with serious respiratory problems to breathe more easily, when oxygen via a face mask alone is insufficient.
Click here to request the download of blueprint to the UCL-Ventura breathing aid.